Lysozyme And Its Uses In The Pharmaceutical Industry

Key Highlights

• Lysozyme is a natural enzyme found in egg whites, tears, saliva, and breast milk
• It destroys bacteria by breaking down their cell walls through a proven biochemical process
• Used in oral liquids, eye drops, injectables, topical products, and drug delivery systems
• Offers a safer, natural alternative to synthetic preservatives in pharmaceutical products
• The global lysozyme market was valued at approximately $113 million in 2024 and is growing at a CAGR of 7.3% to 10.1% through 2032
• Pharmaceutical-grade lysozyme requires verified purity, documented activity levels, and full batch traceability

When you look at what goes into a well-made medicine, most people think about the active drug. But the supporting ingredients matter just as much. One ingredient that often goes unnoticed is lysozyme. It has been used in pharmaceutical formulations for decades, and its role keeps growing.

Lysozyme is a natural antimicrobial enzyme. It is found in the human body, in food sources like egg whites, and in body fluids including tears and breast milk. In the pharmaceutical industry, it serves several real, practical functions. It helps protect medicines from bacterial contamination, supports drug delivery systems, and acts as a natural alternative to synthetic preservatives.

This article breaks down what lysozyme is, how the lysozyme enzyme function works, where it fits in pharmaceutical manufacturing, and what manufacturers need to consider before using it.

What Is Lysozyme?

Lysozyme is an enzyme that the human body produces naturally. It is part of the innate immune system, which is the body’s first line of defense against infection.

You can find it in tears, saliva, nasal mucus, breast milk, and white blood cells. Egg whites are the richest commercial source, which is why most pharmaceutical-grade lysozyme is egg-derived.

Scientifically, lysozyme is classified as a glycoside hydrolase. Its full chemical name is N-acetylmuramide glycanhydrolase. It is also referred to as muramidase in technical and research literature. It is a relatively small protein, weighing just 14.4 kDa, which contributes to its stability and compatibility across formulation types.

So, is lysozyme an enzyme? Yes, it is. Specifically, it is a hydrolase that catalyzes the breakdown of bacterial cell wall structures. That single function has broad implications for how it is used in medicine.

How the Lysozyme Enzyme Function Works

Understanding lysozyme function starts with understanding what bacteria need to survive.

Bacteria are surrounded by a rigid cell wall. That wall is made largely of peptidoglycan, a mesh-like polymer of sugar chains. Peptidoglycan gives the cell wall its strength. Without it, the wall collapses and the bacterium dies.

Lysozyme targets that wall directly. Here is what happens:

1. Lysozyme binds to the sugar chains in the bacterial cell wall
2. It identifies the bond between two specific sugars: N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG)
3. It cleaves that glycosidic bond through hydrolysis
4. The cell wall weakens, internal pressure builds up, and the bacterium ruptures

This process works best against gram-positive bacteria, which have thick, exposed peptidoglycan layers. Gram-negative bacteria have an outer membrane that protects their peptidoglycan layer, which limits lysozyme’s direct enzymatic reach. However, when combined with agents like EDTA, lysozyme can extend its effectiveness to gram-negative organisms as well.

There is also a second way lysozyme fights bacteria. Because lysozyme carries a strong positive charge, it can bind directly to negatively charged bacterial membranes and disrupt them, even without enzymatic activity. This non-enzymatic action gives lysozyme a dual mechanism that makes it more effective than single-action antimicrobial agents.

Key Properties That Make It Valuable in Pharma

Pharmaceutical manufacturers need ingredients that are predictable and stable. Lysozyme delivers on both.

pH stability: Lysozyme stays active across a pH range of roughly 6 to 9. This covers most pharmaceutical formulation environments, from slightly acidic oral liquids to near-neutral ophthalmic solutions.

Thermal stability: The enzyme retains activity up to around 72°C at pH 5.0. This means it can survive certain manufacturing steps that involve controlled heat, without losing its functional properties.

Molecular size and structure: At 14.4 kDa, lysozyme is compact and stable. It interacts well with lipid and polymer-based carrier systems, which makes it relevant for modern drug delivery research.

Isoelectric point: Approximately 11.35. This high positive charge influences how lysozyme interacts with negatively charged excipients, membranes, and polymer matrices, which has practical implications in formulation design.

These properties make lysozyme easier to work with compared to many other biological antimicrobial agents.

Lysozyme Uses in Pharmaceutical Formulations

Enzyme lysozyme shows up in more dosage forms than most people realize. Its role varies depending on the product type and the problem the formulator is trying to solve.

Oral liquids: In syrups and oral suspensions, lysozyme works as an antimicrobial preservative. It inhibits gram-positive bacterial growth during the product’s shelf life, which is especially useful in multi-dose packaging where the container is opened repeatedly.

Ophthalmic products: Human tears naturally contain lysozyme. This makes it highly compatible with eye tissue. In eye drops and ophthalmic solutions, it provides antimicrobial protection without the irritation that some synthetic preservatives cause. This is particularly relevant in formulations for sensitive or pediatric patients.

Injectable products: Sterility is non-negotiable in injectables. Lysozyme can support contamination control during the manufacturing process. For this application, pharmaceutical-grade purity and full validation are essential.

Topical formulations: In wound care gels, dermatological creams, and antimicrobial coatings for medical devices, lysozyme contributes surface-level antimicrobial activity. It has been studied in coatings for catheters, surgical tools, and wound dressings.

Lysozyme in Drug Delivery Systems

Drug delivery has changed significantly over the past two decades. Nanoparticles, liposomes, and polymer matrices now allow drugs to be released at specific times and locations in the body. Lysozyme plays a growing role in these systems.

In liposomal formulations, lysozyme helps protect the lipid carrier from microbial contamination during preparation and storage. This preserves the structure of the carrier and extends the product’s effective shelf life.

In nanoparticle systems, lysozyme’s positive charge allows it to interact with negatively charged polymer matrices. Formulators can use this property to control how quickly a drug is released from the carrier, which is useful in modified-release and targeted therapy products.

Lysozyme has also been explored as an enzyme-responsive trigger in site-specific drug delivery. Some formulations are designed to break down only when they encounter lysozyme at specific sites in the body, such as inflamed tissue or the colon. This approach allows for more precise drug release and fewer side effects.

As of 2025, lysozyme is being actively studied as an “enzybiotic,” a term used for enzymes that act as antibiotic alternatives. This is gaining traction because of growing global concern about antibiotic resistance, and it reflects how seriously the industry is taking lysozyme as a therapeutic and functional ingredient.

Lysozyme as a Natural Preservative in Medicines

Preservative selection is one of the more carefully evaluated decisions in pharmaceutical formulation. Some commonly used synthetic preservatives, including benzalkonium chloride and certain parabens, have raised concerns in specific patient groups, particularly in pediatric, ophthalmic, and long-term use products.

Lysozyme offers a credible natural alternative. Because it is already present in the human body, it is generally well-tolerated. It is effective against gram-positive bacteria and certain fungi, which covers many of the organisms responsible for product spoilage and contamination.

In multi-dose eye drops, oral liquids, and injectable formulations, lysozyme can form part of a preservation strategy that reduces reliance on synthetic agents.

That said, it has real limitations. It does not reliably eliminate gram-negative bacteria on its own. High ionic strength environments, anionic polymers, and certain surfactants can reduce its activity significantly. No responsible pharmaceutical manufacturer should use lysozyme as a sole preservative without product-specific efficacy testing.

Benefits and Limitations

Benefits of lysozyme in pharmaceutical use:

• Natural origin with decades of established safety data
• Two antimicrobial mechanisms: enzymatic and electrostatic
• Compatible with a wide range of formulation types
• Stable across relevant pH and temperature ranges
• Increasingly relevant as an antibiotic resistance alternative
• Well-tolerated in sensitive patient groups when properly formulated

Limitations to be aware of:

• Limited activity against gram-negative bacteria without combination agents
• Activity reduced by anionic excipients, surfactants, and high salt concentrations
• Egg-white origin means allergen considerations apply
• Requires formulation-specific efficacy validation before commercial use
• Not suitable as a standalone preservative for all product types

Read Also : Pharmaceutical Enzyme Manufacturers & Suppliers in India

Quality and Sourcing for the Pharmaceutical Manufacturer

The quality of lysozyme used in pharmaceutical products directly affects safety, stability, and regulatory compliance. A trusted pharmaceutical enzymes manufacturer should supply more than just the ingredient.

When sourcing pharmaceutical-grade lysozyme, look for:

• Batch-specific Certificate of Analysis with confirmed enzymatic activity
• Purity specifications and limits for impurities
• Full source traceability, including egg-white origin documentation
• Allergen declaration for applicable markets
• Stability data relevant to your storage and formulation conditions
• Regulatory support documentation for submissions to health authorities

Recombinant lysozyme, produced through microbial fermentation rather than egg extraction, is becoming a practical alternative. It eliminates the egg allergen concern and can offer more consistent batch-to-batch activity. For allergen-sensitive product categories, it is worth evaluating.

Key Takeaways

• Lysozyme is a natural, proven antimicrobial enzyme with a wide range of pharmaceutical applications
• Its primary function is breaking down bacterial cell walls through peptidoglycan hydrolysis
• It also disrupts bacterial membranes through non-enzymatic electrostatic action
• Applications span oral liquids, ophthalmic products, injectables, topical formulations, and drug delivery systems
• It is a viable natural alternative to synthetic preservatives when properly evaluated and validated
• Quality sourcing, allergen documentation, and batch consistency are critical for pharmaceutical-grade use
• The global lysozyme market is growing steadily, driven by demand for cleaner, safer pharmaceutical ingredients

FAQs

What is lysozyme and why does it matter in pharma?

Lysozyme is a natural antimicrobial enzyme found in egg whites, human tears, saliva, and breast milk. In pharmaceuticals, it matters because it can destroy bacteria, preserve formulations without synthetic chemicals, and support advanced drug delivery systems, all with a strong safety record.

Is lysozyme an enzyme or just a protein?

It is both. Lysozyme is a protein that functions as an enzyme. It belongs to the glycoside hydrolase class and catalyzes the hydrolysis of glycosidic bonds in bacterial cell walls. Its enzymatic activity is what makes it valuable as an antimicrobial agent in pharmaceutical formulations.

What are the main limitations of using lysozyme in pharmaceutical products? 

Lysozyme has limited activity against gram-negative bacteria on its own. Its function can also be reduced by anionic excipients, surfactants, and high salt concentrations. It carries an allergen risk due to its egg-white origin. It should be tested specifically for each formulation and not assumed to work universally.

Can lysozyme be used as a preservative in eye drops and injectables? 

Yes, when sourced at the correct purity grade and validated for the specific formulation. Its natural presence in human tears makes it well-suited for ophthalmic use. For injectables, it must meet strict sterility and purity requirements before use in a commercial product.

What should I expect from a reliable pharmaceutical enzymes manufacturer supplying lysozyme? 

A reliable pharmaceutical enzymes manufacturer should provide batch-specific Certificates of Analysis, confirmed enzymatic activity data, full source documentation, allergen declarations, stability data aligned with your storage conditions, and regulatory support documentation for health authority submissions.

Contact us today for customized enzyme solutions built around your formulation needs. Ultreze Enzymes supplies pharmaceutical-grade lysozyme with verified activity data, full batch documentation, and regulatory support for manufacturers across India and globally.